Elizabeth Holmes Trial Deliberations to Resume on Jan. 3

The jury offered no indication this week of where it is in the deliberation process.

During the nearly four-month trial, the jurors heard from 32 witnesses, including the defendant herself. It all comes down to Ms. Holmes’s intent: Did she mean to defraud investors, patients, advertisers and others in her pursuit of investments and business for Theranos, or was she acting in good faith?

Prosecutors called 29 witnesses — including lab employees, doctors, patients, investors and commercial executives — in their attempt to paint Ms. Holmes as an example of the worst excesses of Silicon Valley’s “fake it until you make it” start-up culture.

Ms. Holmes raised nearly $1 billion from investors and signed contracts with Walgreens and Safeway based on promises of cheaper, easier blood testing. But as The Wall Street Journal revealed in 2015, Theranos’s own devices could perform only 12 tests. The company officially shut down three years later.

​​“She chose fraud over business failure,” Jeff Schenk, an assistant U.S. attorney, said during closing arguments.

Article source: https://www.nytimes.com/2021/12/29/business/elizabeth-holmes-trial-theranos-jury.html